GRHL2 / SENP1 / VDR Signaling Axis: A Key Regulator of SUMOylation and Calcitriol Resistance in SHPT
BioFactors · 2026-03 · 52 (2)
DOI: 10.1002/biof.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 27.02.2026. Verfasst von Yucan Miao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Thyroid Surgery, The Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Calcitriol, Cysteine Endopeptidases, Transcription Factors. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Health Research Project of the Hunan Provincial Health Commission.
Abstract (Originalsprache)
Accumulating evidence suggests that SUMOylation plays a crucial role in the progression and resistance of secondary hyperparathyroidism (SHPT). However, the precise mechanism of SUMOylation in SHPT remains unclear. We identified the potential role of SUMOylation in SHPT based on RNA sequencing data obtained from Gene Expression Omnibus (GEO) datasets. Clinical samples were used to verify the expression of SENP1, SUMO1, SUMO2, GRHL2, and vitamin D receptor (VDR) in SHPT cells and tissues. Primary cells were extracted for subsequent experiments. Plasmid transfection and small interfering RNA (siRNA) were used to modulate SENP1 expression in SHPT primary cells. VDR relative expression was detected by Western blot (WB) and immunofluorescence. The effects of SENP1 on SHPT cell apoptosis and anti‐proliferation were analyzed by flow cytometry and WB. Co‐immunoprecipitation (Co‐IP), chromatin immunoprecipitation (ChIP), and ChIP‐quantitative polymerase chain reaction (ChIP‐qPCR) were employed to explore the regulatory mechanisms of SENP1 in SHPT. We found that SUMOylation was significantly upregulated in SHPT and was closely related to calcitriol resistance. SENP1 and GRHL2 were downregulated. SENP1 was found to upregulate VDR and downregulate the SUMOylation of VDR, which mediates SENP1's regulation of SHPT cell apoptosis and anti‐proliferation. Mechanistically Co‐IP assays revealed binding between VDR, SENP1, SUMO1, and SUMO2. ChIP assays indicated that transcription of SENP1 was regulated by GRHL2, with binding sites identified by ChIP‐qPCR. Additionally, we identified the potential binding pocket of SENP1 and screened 10 candidate small‐molecule drugs approved by the US Food and Drug Administration (FDA). Our findings indicate a distinct mechanism of SENP1‐mediated VDR SUMOylation and establish the critical role of the GRHL2/SENP1/VDR signaling axis in SHPT development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Thyroid Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Thyroid Surgery, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Wei Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Health Research Project of the Hunan Provincial Health Commission
Zitieren
APA
Miao, Y., Ding, Y., Su, H., Wu, R., Li, W., Zhong, C., Qiu, X., & Wu, W. (2026). GRHL2 / SENP1 / VDR Signaling Axis: A Key Regulator of SUMOylation and Calcitriol Resistance in SHPT. BioFactors, 52(2). https://doi.org/10.1002/biof.70086
Vancouver
Miao Y, Ding Y, Su H, Wu R, Li W, Zhong C, et al. GRHL2 / SENP1 / VDR Signaling Axis: A Key Regulator of SUMOylation and Calcitriol Resistance in SHPT. BioFactors. 2026;52(2). doi:10.1002/biof.70086
BibTeX
@article{Miao2026,
author = {Miao, Yucan and Ding, Ying and Su, Han and Wu, Runliu and Li, Wei and Zhong, Cheng and Qiu, Xiangyuan and Wu, Wei},
title = {GRHL2 / SENP1 / VDR Signaling Axis: A Key Regulator of SUMOylation and Calcitriol Resistance in SHPT},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {2},
doi = {10.1002/biof.70086}
}
EUVIMED